Horizon Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Hold
771
0.14% 56
2026
Q1
$226K Sell
771
-334
-30% -$110K 0.11% 70
2025
Q4
$387K Sell
1,105
-236
-18% -$79.8K 0.19% 41
2025
Q3
$433K Buy
1,341
+15
+1% +$4.67K 0.21% 41
2025
Q2
$516K Sell
1,326
-52
-4% -$20.9K 0.26% 42
2025
Q1
$599K Sell
1,378
-2
-0.1% -$803 0.34% 29
2024
Q4
$509K Sell
1,380
-6
-0.4% -$2.51K 0.24% 31
2024
Q3
$721K Buy
1,386
+632
+84% +$338K 0.33% 24
2024
Q2
$409K Hold
754
0.19% 34
2024
Q1
$391K Sell
754
-32
-4% -$15.9K 0.19% 37
2023
Q4
$371K Hold
786
0.18% 33
2023
Q3
$342K Hold
786
0.22% 26
2023
Q2
$349K Hold
786
0.22% 19
2023
Q1
$361K Sell
786
-68
-8% -$32.4K 0.23% 11
2022
Q4
$438K Buy
+854
New +$434K 0.25% 25
2020
Q3
$254K Hold
946
0.36% 82
2020
Q2
$249K Hold
946
0.27% 74
2020
Q1
$215K Hold
946
0.33% 81
2019
Q4
$286K Buy
+946
New +$260K 0.27% 99

Other funds holding ELV

Horizon Bancorp's ELV Position: Q2 2026 in Review

Horizon Bancorp held its Elevance Health (ELV) position steady in Q2 2026 at 771 shares worth $298K. The position accounts for 0.14% of the portfolio, ranked #56.

Horizon Bancorp first reported a position in ELV in Q4 2019 and has held it in 19 quarters since. The position peaked at $721K in Q3 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Horizon Bancorp held 771 shares of Elevance Health worth $298K as of Q2 2026.
  • Horizon Bancorp left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.14% of Horizon Bancorp's portfolio in Q2 2026, its #56 holding.
  • Horizon Bancorp first reported a position in Elevance Health in Q4 2019 and has held it in 19 quarters since.
  • Horizon Bancorp's Elevance Health position peaked at $721K in Q3 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Horizon Bancorp's 13F filing for Q2 2026, filed 4 Aug 2026.